Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

NCT03026192 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2019-01-23

No results posted yet for this study

Summary

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Conditions

  • Patent Ductus Arteriosus

Interventions

DEVICE

near infrared spectroscopy

Near infrared spectroscopy will be placed on infants both with and without hsPDA

Sponsors & Collaborators

  • Albany Medical College

    lead OTHER

Eligibility

Min Age
1 Minute
Max Age
1 Week
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03026192 on ClinicalTrials.gov